Abbvie Inc [ABBV] stock prices are up 0.26% to $175.26 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ABBV shares have gain 3.58% over the last week, with a monthly amount drifted -2.20%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Daiwa Securities downgraded its rating to Neutral on December 05, 2024, and kept the price target unchanged to $180. On November 22, 2024, upgrade upgraded it’s rating to Outperform but maintained its price target of $206 on the stock. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $205 on November 15, 2024. Argus upgraded its rating to a Buy. Bernstein started tracking with a Mkt Perform rating for this stock on October 17, 2024, and assigned it a price target of $203. In a note dated June 05, 2024, HSBC Securities upgraded an Buy rating on this stock but restated the target price of $185.
The stock price of Abbvie Inc [ABBV] has been fluctuating between $153.58 and $207.32 over the past year. Currently, Wall Street analysts expect the stock to reach $211.2 within the next 12 months. Abbvie Inc [NYSE: ABBV] shares were valued at $175.26 at the most recent close of the market. An investor can expect a potential return of 20.51% based on the average ABBV price forecast.
Analyzing the ABBV fundamentals
The Abbvie Inc [NYSE:ABBV] reported sales of 55.53B for trailing twelve months, representing a surge of 3.83%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.25%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.66 and Total Capital is 0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of11.78.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 174.07 points at the first support level, and at 172.87 for the second support level. However, for the 1st resistance point, the stock is sitting at 176.69, and for the 2nd resistance point, it is at 178.11.
Ratios To Look Out For
It’s worth pointing out that Abbvie Inc [NYSE:ABBV]’s Current Ratio is 0.65. In addition, the Quick Ratio stands at 0.54 and the Cash Ratio stands at 0.17. Considering the valuation of this stock, the price to sales ratio is 5.58, the price to book ratio is 51.34 and price to earnings (TTM) ratio is 61.12.
Transactions by insiders
Recent insider trading involved Buckbee Kevin K, SVP, CONTROLLER, that happened on Dec 16 ’24 when 1800.0 shares were sold. Officer, Buckbee Kevin K completed a deal on Dec 16 ’24 to buy 1800.0 shares. Meanwhile, Officer Hudson Thomas J bought 49170.0 shares on Aug 08 ’24.
